Bill > HR220

This resolution designates the week of May 4 through 10, 2025, as "Tardive Dyskinesia Awareness Week" in Pennsylvania to raise public and medical community awareness about tardive dyskinesia (TD), a neurological disorder characterized by involuntary, repetitive movements that can affect individuals taking dopamine receptor blocking agents (DRBAs) for mental health conditions like bipolar disorder, schizophrenia, or for gastrointestinal issues. The resolution highlights that approximately 800,000 people in the United States are affected by TD, with about 60% remaining undiagnosed, and emphasizes the importance of regular medical screenings as recommended by the American Psychiatric Association. By designating this awareness week, the Pennsylvania House of Representatives aims to encourage better understanding of TD, its symptoms, and potential treatments, recognizing that even mild TD symptoms can significantly impact a person's physical, social, and emotional well-being. The resolution also notes that clinical research has led to FDA-approved treatments for adults with TD, underscoring the potential for positive outcomes through recognition and appropriate medical intervention.

Health and Social Services

https://www.legis.state.pa.us/cfdocs/billinfo/bill_history.cfm?syear=2025&sind=0&body=H&type=R&bn=220